Latest scientific publications

Reframing sepsis immunobiology for translation: towards informative subtyping and targeted immunomodulatory therapies.
Auteurs Shankar-Hari M, Calandra T, Soares MP, Bauer M, Wiersinga WJ, Prescott HC, Knight JC, Baillie KJ, Bos LDJ, Derde LPG, Finfer S, Hotchkiss RS, Marshall J, Openshaw PJM, Seymour CW, Venet F, Vincent JL, Le Tourneau C, Maitland-van der Zee AH, McInnes IB, van der Poll T
Revue Lancet Respir Med
Date de publication 2024-02

Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.
Auteurs Kowdley KV, Bowlus CL, Levy C, Akarca US, Alvares-da-Silva MR, Andreone P, Arrese M, Corpechot C, Francque SM, Heneghan MA, Invernizzi P, Jones D, Kruger FC, Lawitz E, Mayo MJ, Shiffman ML, Swain MG, Valera JM, Vargas V, Vierling JM, Villamil A, Addy C, Dietrich J, Germain JM, Mazain S, Rafailovic D, Taddé B, Miller B, Shu J, Zein CO, Schattenberg JM
Revue N Engl J Med
Date de publication 2024-02

Correction: Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions.
Auteurs Pradeep C-, Zeisel A, Köstler WJ, Lauriola M, Jacob-Hirsch J, Haibe-Kains B, Amariglio N, Ben-Chetrit N, Emde A, Solomonov I, Neufeld G, Piccart M, Sagi I, Sotiriou C, Rechavi G, Domany E, Desmedt C, Yarden Y
Revue Oncogene
Date de publication 2024-02

Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression.
Auteurs Bardia A, Rugo HS, Tolaney SM, Loirat D, Punie K, Oliveira M, Brufsky A, Kalinsky K, Cortés J, Shaughnessy JO, Diéras V, Carey LA, Gianni L, Piccart-Gebhart M, Loibl S, Yoon OK, Pan Y, Hofsess S, Phan SC, Hurvitz SA
Revue J Clin Oncol
Date de publication 2024-02

Risk Factors and Innovations in Risk Assessment for Melanoma, Basal Cell Carcinoma, and Squamous Cell Carcinoma.
Auteurs Wunderlich K, Suppa M, Gandini S, Lipski J, White JM, Del Marmol V
Revue Cancers (Basel)
Date de publication 2024-02

Endoscopic Submucosal Dissection Is Safe and Effective for Lesions Located at the Anorectal Junction: Analysis from Two Referral European Centers.
Auteurs Ferreira MF, Marques M, Morais R, Lemmers A, Macedo G, Santos-Antunes J
Revue GE Port J Gastroenterol
Date de publication 2024-02

The Impact of Initial Tumor Response on Survival Outcomes of Patients With HER2-Positive Advanced Breast Cancer Treated With Docetaxel, Trastuzumab, and Pertuzumab: An Exploratory Analysis of the CLEOPATRA Trial.
Auteurs Debien V, Agostinetto E, Bruzzone M, Ceppi M, Martins-Branco D, Molinelli C, Jacobs F, Nader-Marta G, Lambertini M, de Azambuja E
Revue Clin Breast Cancer
Date de publication 2024-02

Influence of Sevoflurane on the Neurological Pupil Index in Surgical and Critically Ill Patients: A Pilot Study.
Auteurs Dallemagne A, Anderloni M, Havaux M, Duranteau O, Taccone FS
Revue Brain Sci
Date de publication 2024-02

Diagnostic Pitfalls of Macrocephaly and Intracranial Dural Arteriovenous Fistulas: Connecting the Dots With the Red Flags.
Auteurs Andrei A, Saliba T, Lubicz B, Fricx C
Revue Cureus
Date de publication 2024-02

Jules Bordet Institute

View all of Jules Bordet's scientific publications

Scientific publications by Jules Bordet

View all of Erasme's scientific publications

Erasme's academic publications

View all scientific publications from the Queen Fabiola Children's Hospital

Scientific publications from the Queen Fabiola Children's Hospital